Laser Skin Rejuvenation

ACPS med spa uses the Sciton BBL HERO and MOXI laser platforms for non-ablative skin rejuvenation, targeting pigmentation irregularities, vascular lesions, diffuse redness, and overall skin quality. BBL (BroadBand Light) delivers intense pulsed light in precise wavelength bands to address sunspots, age spots, rosacea, and small vascular lesions while promoting collagen synthesis in the dermis. MOXI is a non-ablative 1927 nm fractional thulium laser that addresses superficial texture, early photodamage, and skin tone, with minimal downtime compared to ablative resurfacing. Treatments may be combined in a single session (Forever Young BBL protocol) and are safe across a range of skin types.

Laser and light-based skin rejuvenation at the Aesthetic Center for Plastic Surgery Houston operates through the Sciton platform, which encompasses the BBL HERO (BroadBand Light High Energy Rapid) and MOXI fractional thulium laser systems. These two devices complement each other across the spectrum of photodamage and skin quality concerns, and are frequently combined in a single treatment session for comprehensive results. BBL HERO is the highest-powered broadband light system available, delivering pulsed intense light energy across customisable wavelength bands from 515 nm to 1,200 nm, filtered to target specific chromophores. At the 515–580 nm range, BBL energy is absorbed selectively by oxyhemoglobin in dilated superficial blood vessels and by melanin in pigmented lesions — the thermal energy absorbed by these targets causes vessel coagulation and pigment fragmentation, respectively, leading to the clearance of visible redness, spider telangiectasia, rosacea flushing, solar lentigines, seborrheic keratoses, and freckles over one to two weeks as the body clears the treated targets. BBL also induces thermal stimulation of the dermis, prompting collagen synthesis and improving skin texture and firmness. The well-known 'Forever Young BBL' protocol, developed from Stanford research, involves annual maintenance sessions that ACPS providers offer to patients interested in the long-term skin quality management data supporting this approach. MOXI is a non-ablative fractional 1927 nm thulium laser that creates a mosaic of microscopic treatment zones in the superficial epidermis and papillary dermis, stimulating epidermal turnover and early collagen remodelling while leaving the skin barrier largely intact. The fractional delivery — treating only a portion of the skin surface per pass — permits rapid healing within two to three days, characterised by a 'MESTs' response (microscopic epidermal necrotic debris) that sloughs over one to four days as new, healthier skin resurfaces. MOXI is particularly effective for early photodamage, generalised uneven skin tone, and the subtle textural irregularities of early photoageing, and is suitable for a broader range of skin tones than more aggressive ablative systems. ACPS providers frequently combine BBL and MOXI in a single appointment — addressing both the pigmentation and vascular components of photodamage with BBL, and the textural and epidermal turnover component with MOXI — for comprehensive results in a single session with two to four days of social downtime.